Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert P van Manen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Safety|August 11, 2007
Signal detection methodologies to support effective safety managementRobbert P van Manen, David Fram, William DuMouchel
Pharmacotherapy|November 26, 2014
How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system databaseTina M Khadem, Robbert P van Manen, Jack Brown
Pharmacotherapy|September 20, 2011
Potential for linezolid-related blindness: a review of spontaneous adverse event reportsJack Brown, Samuel L Aitken, Robbert P van Manen
The Annals of Pharmacotherapy|October 26, 2019
A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related HypoglycemiaKatherine M Juba, Robbert P van Manen, Shawn E Fellows
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 9, 2018
Signal detection for bleeding associated with the use of direct oral anticoagulantsKobi T Nathan, Kelly M Conn, Robbert P van Manen, et al.
The Annals of Pharmacotherapy|October 27, 2015
Dipeptidyl Peptidase-4 Inhibitor-Associated Pancreatic Carcinoma: A Review of the FAERS DatabaseAngela K Nagel, Nabila Ahmed-Sarwar, Paul M Werner, et al.
Frontiers in Pharmacology|March 6, 2023
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBaseVera Battini, Robbert P Van Manen, Michele Gringeri, et al.
Expert Opinion on Biological Therapy|June 30, 2021
The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) databaseFaizan Mazhar, Vera Battini, Michele Gringeri, et al.
Expert Opinion on Drug Safety|August 8, 2025
Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscapeMaria Antonietta Barbieri, Vera Battini, Carla Carnovale, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Safety|August 11, 2007
Signal detection methodologies to support effective safety managementRobbert P van Manen, David Fram, William DuMouchel
Pharmacotherapy|November 26, 2014
How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system databaseTina M Khadem, Robbert P van Manen, Jack Brown
Pharmacotherapy|September 20, 2011
Potential for linezolid-related blindness: a review of spontaneous adverse event reportsJack Brown, Samuel L Aitken, Robbert P van Manen
The Annals of Pharmacotherapy|October 26, 2019
A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related HypoglycemiaKatherine M Juba, Robbert P van Manen, Shawn E Fellows
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 9, 2018
Signal detection for bleeding associated with the use of direct oral anticoagulantsKobi T Nathan, Kelly M Conn, Robbert P van Manen, et al.
The Annals of Pharmacotherapy|October 27, 2015
Dipeptidyl Peptidase-4 Inhibitor-Associated Pancreatic Carcinoma: A Review of the FAERS DatabaseAngela K Nagel, Nabila Ahmed-Sarwar, Paul M Werner, et al.
Frontiers in Pharmacology|March 6, 2023
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBaseVera Battini, Robbert P Van Manen, Michele Gringeri, et al.
Expert Opinion on Biological Therapy|June 30, 2021
The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) databaseFaizan Mazhar, Vera Battini, Michele Gringeri, et al.
Expert Opinion on Drug Safety|August 8, 2025
Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscapeMaria Antonietta Barbieri, Vera Battini, Carla Carnovale, et al.
Pageof 1